Increased Ca2+ signaling in NRXN1α +/− neurons derived from ASD induced pluripotent stem cells
Abstract Background Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a high co-morbidity of epilepsy and associated with hundreds of rare risk factors. NRXN1 deletion is among the commonest rare genetic factors shared by ASD, schizophrenia, intellectual disability, epilepsy, and...
Main Authors: | Sahar Avazzadeh, Katya McDonagh, Jamie Reilly, Yanqin Wang, Stephanie D. Boomkamp, Veronica McInerney, Janusz Krawczyk, Jacqueline Fitzgerald, Niamh Feerick, Matthew O’Sullivan, Amirhossein Jalali, Eva B. Forman, Sally A. Lynch, Sean Ennis, Nele Cosemans, Hilde Peeters, Peter Dockery, Timothy O’Brien, Leo R. Quinlan, Louise Gallagher, Sanbing Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Molecular Autism |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13229-019-0303-3 |
Similar Items
-
NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons
by: Sahar Avazzadeh, et al.
Published: (2021-09-01) -
Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot Study
by: Aleksandra Skiba, et al.
Published: (2021-07-01) -
NRXN1 Deletion in Two Twins’ Genotype and Phenotype: A Clinical Case and Literature Review
by: Monica Sciacca, et al.
Published: (2022-05-01) -
A case-control association study of <it>NRXN1 </it>polymorphisms with schizophrenia in Chinese Han population
by: Lu Tianlan, et al.
Published: (2011-04-01) -
Mutation analysis of the NRXN1 gene in autism spectrum disorders
by: Onay H, et al.
Published: (2016-12-01)